InvestorsHub Logo
Followers 84
Posts 32240
Boards Moderated 85
Alias Born 03/22/2005

Re: Johnny_C post# 4130

Friday, 05/17/2019 10:05:17 AM

Friday, May 17, 2019 10:05:17 AM

Post# of 5001
>> AXSM <<


AXSM is a no brainer, with very high odds of success and approval, hence the stock performance. The market cap will likely run up to $1 bil and then wait for clinical news flow, of which there is a ton coming. Current market cap is 767 mil.

Personally I don't bet on bio stocks anymore, just watch out of general interest/hobby.

Good luck with VTGN. If the Elevate trial dosed longer, even 4 weeks, it might be worth a small gamble. At 2 weeks forget it.






































Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VTGN News